{"id":668,"date":"2013-10-31T22:01:56","date_gmt":"2013-10-31T22:01:56","guid":{"rendered":"http:\/\/www.wi.rwth-aachen.de\/SmartMedCN\/?p=668"},"modified":"2013-10-31T22:01:56","modified_gmt":"2013-10-31T22:01:56","slug":"high-accounts-receivable-for-shanghai-pharmaceutical-holding","status":"publish","type":"post","link":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/2013\/10\/31\/high-accounts-receivable-for-shanghai-pharmaceutical-holding\/","title":{"rendered":"High Accounts Receivable for Shanghai Pharmaceutical Holding"},"content":{"rendered":"<p><strong>Shanghai Pharmaceutical Holding announced third quarter net earnings of 1,67 billion Yuan, which is 8,46% higher compared to the amount reported during the same period last year. However, there were 4 billion Yuan accounts receivable created in the first three quarters this year, and the total company accounts receivable reached 12,6 billion Yuan. The figure shows that a great part of company incomes are not received yet, some experts are worried about the company liquidity. Actually most of Chinese pharmaceutical companies face the same challenge.<\/strong><\/p>\n<p>&nbsp;<\/p>\n<h3>\u4e09\u5b63\u5ea6\u5e94\u6536\u8d26\u6b3e166\u4ebf\u5143 \u4e0a\u6d77\u533b\u836f\u9677\u503a\u52a1\u56f0\u5c40<\/h3>\n<p>\u6765\u6e90\uff1a\u8bc1\u5238\u65e5\u62a5<br \/>\n\u6838\u5fc3\u63d0\u793a\uff1a\u4e0a\u6d77\u533b\u836f\u4e09\u5b63\u62a5\u663e\u793a\uff0c\u516c\u53f81\u6708\u81f39\u6708\u5b9e\u73b0\u8425\u4e1a\u6536\u5165580\u4ebf\u5143\uff0c\u5b9e\u73b0\u5f52\u5c5e\u4e8e\u4e0a\u5e02\u516c\u53f8\u80a1\u4e1c\u7684\u51c0\u5229\u6da6\u4e3a16.7\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f8.46%.\u540c\u65f6\uff0c\u516c\u53f8 \u7684\u5e94\u6536\u8d26\u6b3e\u5374\u9ad8\u8fbe166\u4ebf\u5143\uff0c\u5e74\u521d\u8be5\u503c\u4e3a126\u4ebf\u5143\uff0c\u8fd9\u610f\u5473\u7740\u4eca\u5e74\u516c\u53f8\u65b0\u589e\u7684\u5e94\u6536\u8d26\u6b3e\u4e3a40\u4ebf\u5143\uff0c\u53d8\u52a8\u5e45\u5ea6\u4e3a32%\uff0c\u662f\u516c\u53f8\u51c0\u5229\u6da6\u76842.3\u500d\u3002<\/p>\n<p>10\u670826\u65e5\uff0c\u4e0a\u6d77\u533b\u836f\u516c\u5e03\u4e86\u516c\u53f8\u524d\u4e09\u5b63\u5ea6\u7684\u4e1a\u7ee9\u3002<\/p>\n<p>\u4e0a\u6d77\u533b\u836f\u4e09\u5b63\u62a5\u663e\u793a\uff0c\u516c\u53f81\u6708\u81f39\u6708\u5b9e\u73b0\u8425\u4e1a\u6536\u5165580\u4ebf\u5143\uff0c\u5b9e\u73b0\u5f52\u5c5e\u4e8e\u4e0a\u5e02\u516c\u53f8\u80a1\u4e1c\u7684\u51c0\u5229\u6da6\u4e3a16.7\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f8.46%.\u540c\u65f6\uff0c\u516c\u53f8\u7684\u5e94\u6536\u8d26\u6b3e\u5374\u9ad8\u8fbe166\u4ebf\u5143\uff0c\u5e74\u521d\u8be5\u503c\u4e3a126\u4ebf\u5143\uff0c\u8fd9\u610f\u5473\u7740\u4eca\u5e74\u516c\u53f8\u65b0\u589e\u7684\u5e94\u6536\u8d26\u6b3e\u4e3a40\u4ebf\u5143\uff0c\u53d8\u52a8\u5e45\u5ea6\u4e3a32%\uff0c\u662f\u516c\u53f8\u51c0\u5229\u6da6\u76842.3\u500d\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u4e0a\u6d77\u533b\u836f\u524d\u4e09\u5b63\u5ea6\u7ecf\u8425\u6027\u73b0\u91d1\u6d41\u91cf\u4ec5\u4e3a5.52\u4ebf\u5143\u3002\u6709\u5206\u6790\u4eba\u58eb\u8ba4\u4e3a\uff0c\u8fd9\u610f\u5473\u7740\u516c\u53f8\u524d\u4e09\u5b63\u5ea6\u6536\u5230\u7684\u771f\u91d1\u767d\u94f6\u8fdc\u4f4e\u4e8e\u8d26\u9762\u4e0a\u7684\u6570\u989d\u3002\u5bf9\u6b64\uff0c\u6709\u4f1a\u8ba1\u5e08\u8868\u793a\uff0c \u8fc7\u591a\u7684\u5e94\u6536\u8d26\u6b3e\u4e0d\u4f46\u589e\u52a0\u4f01\u4e1a\u7684\u7ba1\u7406\u6210\u672c\u548c\u8d44\u91d1\u6210\u672c\uff0c\u4e5f\u4e25\u91cd\u5f71\u54cd\u4e86\u4f01\u4e1a\u7684\u8d44\u91d1\u6d41\u52a8\u6027\uff0c\u4e00\u5bb6\u826f\u6027\u53d1\u5c55\u7684\u4f01\u4e1a\u5e94\u8be5\u4e25\u683c\u63a7\u5236\u5e94\u6536\u8d26\u6b3e\u7684\u6570\u989d\u3002<\/p>\n<p>\u7136\u800c\uff0c\u572810\u670828\u65e5\u4e3e\u884c\u7684\u4e1a\u7ee9\u8bf4\u660e\u4f1a\u4e0a\uff0c\u6709\u6295\u8d44\u8005\u5411\u516c\u53f8\u7ba1\u7406\u5c42\u63d0\u51fa\u5e94\u6536\u8d26\u6b3e\u8fc7\u9ad8\u8fd9\u4e00\u95ee\u9898\u3002\u4e0a\u6d77\u533b\u836f\u76f8\u5173\u4eba\u58eb\u56de\u5e94\u79f0\uff0c\u516c\u53f8\u7684\u5e94\u6536\u8d26\u6b3e\u90fd\u4fdd\u6301\u7740\u4e00\u5b9a\u7684\u6c34\u5e73\uff0c\u516c\u53f8\u5bf9\u5176\u6709\u5408\u7406\u7684\u63a7\u5236\u3002<\/p>\n<p>\u5e94\u6536\u8d26\u6b3e\u589e\u5e45\u9ad8<\/p>\n<p>\u636e\u6570\u636e\uff0c\u622a\u6b62\u52309\u670830\u65e5\uff0c\u4e0a\u6d77\u533b\u836f\u7684\u5e94\u6536\u8d26\u6b3e\u6570\u989d\u662f\u5df2\u53d1\u5e03\u4e09\u5b63\u62a5\u7684\u533b\u836f\u751f\u7269\u4e0a\u5e02\u516c\u53f8\u4e2d\u5e94\u6536\u8d26\u6b3e\u6700\u591a\u7684\u516c\u53f8\u3002<\/p>\n<p>\u4e0a\u6d77\u533b\u836f\u4e09\u5b63\u62a5\u663e\u793a\uff0c\u6570\u636e\u663e\u793a\uff0c\u516c\u53f8\u603b\u8d44\u4ea7\u4e3a549\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f7.69%\uff1b\u51c0\u8d44\u4ea7\u4e3a253\u4ebf\u5143\uff0c\u540c\u6bd4\u589e\u957f3%.\u800c\u516c\u53f8\u7684\u5e94\u6536\u8d26\u6b3e\u5374\u9ad8\u8fbe166\u4ebf\u5143\uff0c\u53bb\u5e74\u540c\u671f\u8be5\u503c\u4e3a148\u4ebf\u5143\uff0c\u8fd9\u610f\u5473\u7740\u4e0a\u6d77\u533b\u836f\u4eca\u5e74\u7684\u5e94\u6536\u8d26\u6b3e\u540c\u6bd4\u589e\u957f12%\uff0c\u516c\u53f8\u5e94\u6536\u8d26\u6b3e\u7684\u6da8\u5e45\u660e\u663e\u9ad8\u4e8e\u4e1a\u7ee9\u7684\u589e\u957f\u3002<\/p>\n<p>\u5bf9\u6b64\uff0c\u516c\u53f8\u5728\u4e09\u5b63\u62a5\u4e2d\u8868\u793a\uff0c\u4e3b\u8981\u662f\u56e0\u4e3a\u62a5\u544a\u671f\u5185\u4e3b\u8425\u4e1a\u52a1\u589e\u957f\u6240\u81f4\u3002<\/p>\n<p>\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u4ece2011\u5e74\u5f00\u59cb\uff0c\u4e0a\u6d77\u533b\u836f\u7684\u5e94\u6536\u8d26\u6b3e\u5c31\u4e0a\u5347\u5230\u767e\u4ebf\u5143\u7684\u6c34\u5e73\u3002\u636e\u6570\u636e\uff0c\u4e0a\u6d77\u533b\u836f2011\u5e74\u7684\u5e94\u6536\u8d26\u6b3e\u4e3a106\u4ebf\u5143\uff0c\u603b\u8d44\u4ea7\u4e3a476\u4ebf\u5143\uff0c\u5e94 \u6536\u8d26\u6b3e\u5360\u5176\u603b\u8d44\u4ea7\u7684\u6bd4\u4f8b\u4e3a22%\uff1b2012\u5e74\u8be5\u503c\u4e3a126\u4e07\u5143\uff0c\u603b\u8d44\u4ea7\u4e3a510\u4ebf\u5143\uff0c\u5e94\u6536\u8d26\u6b3e\u5360\u5176\u603b\u8d44\u4ea7\u7684\u6bd4\u4f8b\u4e3a24%\uff0c\u800c2013\u5e74\u524d\u4e09\u5b63\u5ea6\uff0c\u4e0a\u6d77\u533b\u836f \u7684\u5e94\u6536\u8d26\u6b3e\u5360\u516c\u53f8\u603b\u8d44\u4ea7\u7684\u6bd4\u4f8b\u5df2\u4e0a\u5347\u81f330%\uff0c\u5360\u51c0\u8d44\u4ea7\u7684\u6bd4\u4f8b\u4e3a65%.<\/p>\n<p>\u572810\u670828\u65e5\u4e3e\u884c\u7684\u4e09\u5b63\u5ea6\u4e1a\u7ee9\u8bf4\u660e\u7535\u8bdd\u4f1a\u8bae\u4e2d\uff0c\u4e0a\u6d77\u533b\u836f\u56de\u5e94\u79f0\uff0c\u516c\u53f8\u7684\u5e94\u6536\u8d26\u6b3e\u6700\u8fd1\u51e0\u4e2a\u5b63\u5ea6\u4e00\u76f4\u4fdd\u6301\u5728\u767e\u4ebf\u5143\u4ee5\u4e0a\uff0c\u6ce2\u52a8\u6027\u8f83\u5c0f\uff0c\u76ee\u524d\u516c\u53f8\u7684\u5e94\u6536\u8d26\u6b3e\u95ee\u9898\u90fd\u5728\u63a7\u5236\u4e4b\u4e2d\u3002<\/p>\n<p>\u7136\u800c\uff0c\u516c\u53f8\u7684\u534a\u5e74\u62a5\u663e\u793a\uff0c\u4e0a\u534a\u5e74\uff0c\u516c\u53f8\u7684\u5e94\u6536\u8d26\u6b3e\u4e3a168\u4ebf\u5143\uff0c\u5176\u4e2d\uff0c\u574f\u8d26\u51c6\u5907\u4e3a7.87\u4ebf\u5143\u3002\u516c\u53f8\u5e94\u6536\u8d26\u6b3e\u7684\u8d26\u9f84\u5206\u522b\u4e3a\uff1a\u4e09\u5e74\u4ee5\u4e0a\u8d26\u9f84\u7684\u5e94\u6536\u8d26\u6b3e\u4e3a 6.27\u4ebf\u5143\uff0c\u4e8c\u5e74\u5230\u4e09\u5e74\u8d26\u9f84\u7684\u5e94\u6536\u8d26\u6b3e\u4e3a5402\u4e07\u5143\uff0c\u4e00\u5e74\u5230\u4e8c\u5e74\u8d26\u9f84\u7684\u5e94\u6536\u8d26\u6b3e\u4e3a2.75\u4ebf\u5143\uff0c\u4e00\u5e74\u4ee5\u5185\u7684\u5e94\u6536\u8d26\u6b3e\u4e3a159\u4ebf\u5143\u3002<\/p>\n<p>\u5b58\u8d27\u4e0d\u65ad\u589e\u957f<\/p>\n<p>\u9664\u4e86\u9762\u5bf9\u5e94\u6536\u8d26\u6b3e\u7684\u538b\u529b\uff0c\u4e0a\u6d77\u533b\u836f\u8fd8\u9700\u9762\u4e34\u7684\u662f\u4e0d\u65ad\u589e\u957f\u7684\u5b58\u8d27\u7684\u538b\u529b\u3002<\/p>\n<p>\u5728\u516c\u53f8\u7684\u534a\u5e74\u62a5\u91cc\uff0c\u8bb0\u8005\u4e86\u89e3\u5230\uff0c\u516c\u53f8\u7684\u5b58\u8d27\u5305\u62ec\u539f\u6750\u6599\u3001\u5728\u9014\u7269\u8d44\u3001\u5468\u8f6c\u6750\u6599\u3001\u4ea7\u6210\u54c1\u3001\u5728\u4ea7\u54c1\u3001\u81ea\u5236\u534a\u6210\u54c1\u3001\u59d4\u6258\u52a0\u5de5\u7269\u8d44\u548c\u6d88\u8017\u6027\u751f\u7269\u8d44\u4ea7\u7b49\u3002<\/p>\n<p>\u516c\u53f82013\u5e74\u534a\u5e74\u62a5\u663e\u793a\uff0c1\u6708\u81f36\u6708\uff0c\u516c\u53f8\u7684\u5b58\u8d27\u4e3a94.7\u4ebf\u5143\u3002\u5176\u4e2d\u4ea7\u6210\u54c1\u7684\u5b58\u8d27\u7ea6\u4e3a83\u4ebf\u5143\uff0c\u5360\u5b58\u8d27\u7684\u6bd4\u4f8b\u8fbe88%.<\/p>\n<p>\u4eca\u5e74\u4e09\u5b63\u5ea6\uff0c\u516c\u53f8\u7684\u5b58\u8d27\u7ee7\u7eed\u589e\u52a0\u3002\u6570\u636e\u663e\u793a\uff0c\u4eca\u5e74\u524d\u4e09\u5b63\u5ea6\uff0c\u516c\u53f8\u7684\u5b58\u8d27\u989d\u5ea6\u4e3a97.69\u4ebf\u5143\uff0c\u662f\u76ee\u524d\u5df2\u516c\u5e03\u4e1a\u7ee9\u7684\u533b\u836f\u751f\u7269\u516c\u53f8\u4e2d\u5b58\u8d27\u989d\u5ea6\u6700\u591a\u7684\u4e0a\u5e02\u516c\u53f8\u3002<\/p>\n<p>\u53e6\u5916\uff0c\u53bb\u5e74\u540c\u671f\u516c\u53f8\u7684\u5b58\u8d27\u4e3a87.8\u4ebf\u5143\uff0c2011\u5e74\u8be5\u503c\u4e3a74\u4ebf\u5143\u30022012\u5e74\u548c2013\u5e74\u516c\u53f8\u5b58\u8d27\u7684\u589e\u957f\u6bd4\u7387\u5206\u522b\u4e3a17%\u548c11%\uff0c\u540c\u6837\u4e5f\u8d85\u8fc7\u4e86\u51c0\u5229\u6da6\u7684\u589e\u957f\u901f\u5ea6\u3002<\/p>\n<p>\u8ba9\u6295\u8d44\u8005\u5173\u5fc3\u7684\u662f\uff0c\u516c\u53f8\u524d\u4e09\u5b63\u5ea6\u7684\u5e94\u6536\u8d26\u6b3e\u548c\u5b58\u8d27\u8fde\u7eed\u591a\u5e74\u4e0a\u6da8\uff0c\u4e14\u4e8c\u8005\u5360\u516c\u53f8\u603b\u8d44\u4ea7\u7684\u6bd4\u4f8b\u8f83\u9ad8\u3002\u8fd9\u4e00\u7b97\u6765\uff0c\u524d\u4e09\u5b63\u5ea6\uff0c\u516c\u53f8\u7684\u5b58\u8d27\u548c\u5e94\u6536\u8d26\u6b3e\u603b\u8ba1\u8d85263\u4ebf\u5143\uff0c\u5360\u516c\u53f8\u603b\u8d44\u4ea7\u7684\u6bd4\u4f8b\u4e3a47%\uff0c\u800c\u8fdc\u8d85\u4e86\u516c\u53f8\u7684\u51c0\u8d44\u4ea7\u8fd110\u4ebf\u5143\u3002<\/p>\n<p>\u5728\u4e09\u5b63\u62a5\u4e2d\uff0c\u516c\u53f8\u8868\u793a\uff0c\u672a\u6765\u533b\u836f\u670d\u52a1\u4e1a\u52a1\u5c06\u52a0\u5f3a\u5e94\u6536\u8d26\u6b3e\u548c\u4e24\u9879\u8d39\u7528\u7ba1\u7406\uff0c\u964d\u4f4e\u5e93\u5b58\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shanghai Pharmaceutical Holding announced third quarter net earnings of 1,67 billion Yuan, which is 8,46% higher compared to the amount reported during the same period last year. However, there were [&hellip;]<\/p>\n","protected":false},"author":951,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"c2c_always_allow_admin_comments":false,"footnotes":""},"categories":[5],"tags":[12],"class_list":["post-668","post","type-post","status-publish","format-standard","hentry","category-pharmaceutical-company-news","tag-drug-distribution"],"_links":{"self":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/users\/951"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/comments?post=668"}],"version-history":[{"count":0,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/668\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/media?parent=668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/categories?post=668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/tags?post=668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}